What is Rogalife?
Rogalife is at the forefront of developing advanced stress relief solutions, primarily through its Roga Device and Roga AI. The company is dedicated to providing individuals with fast, effective, and convenient methods for immediate stress management. Leveraging scientific research and continuous innovation, Rogalife offers resources and support systems designed to help users effectively manage stress. Their focus on science-backed tools positions them as a key player for individuals seeking efficient stress management techniques.
How much funding has Rogalife raised?
Rogalife has raised a total of $1.2M across 1 funding round:
Other Financing Round
$1.2M
Other Financing Round (2024): $1.2M with participation from Exceptional Ventures, MindEd Ventures, and Ontario Brain Institute
Key Investors in Rogalife
Exceptional Ventures
Exceptional Ventures is a London-based venture capital firm that invests in early-stage companies focused on enhancing human longevity, health, and happiness. They partner with innovative founders to drive scientifically proven advancements in wellness, risk assessment, and care delivery.
MindEd Ventures
MindEd Ventures focuses on investing in early-stage start-ups developing scalable mental fitness tools. They provide funding for pre-Series A start-ups emphasizing data-driven brain training and increasing access to mental wellness support.
Ontario Brain Institute
The Ontario Brain Institute aims to position Ontario as a global leader in brain research, commercialization, and care, mobilizing research excellence to improve the quality of life for individuals with brain disorders and engaging with industry to foster investments in neuroscience technologies.
What's next for Rogalife?
With this major strategic investment, Rogalife is poised for significant expansion and further development of its stress relief technologies. The enterprise-level backing suggests a focus on scaling operations, enhancing AI capabilities, and potentially broadening market reach. Future initiatives will likely involve deepening the scientific validation of their products and expanding their service offerings to cater to a wider audience seeking proactive mental wellness solutions. This capital injection is expected to accelerate their mission to make effective stress relief accessible.
See full Rogalife company page
